Copernicus Group IRB Enter Strategic Alliance with IRB Services in Canada
Research Triangle Park, NC and Aurora, ON Canada - September 7, 2010 - Copernicus Group IRB (CGIRB), a leading independent institutional review board, today announced a new strategic alliance with IRB Services of Canada. This partnership will enable CGIRB to offer institutional review services to its clients whose clinical research protocols include Canadian sites. The objective of this alliance is to provide CGIRB clients a single solution for ethical review of clinical research protocols and sites in North America.
Each client will work with a dedicated CGIRB single point of contact with team support bridging both IRBs. The integrated team will ensure an expeditious and thorough ethical review and quality client service in full compliance with regulatory and ethical requirements in both countries.
“This alliance will benefit both organizations by providing a seamless service to CGIRB clients who plan to include Canadian sites in addition to US research,” said Jack Corman, CEO and Founder of IRB Services. “I am delighted to be partnering with Copernicus Group IRB, one of the leading independent IRBs in the United States.”
This new alliance, coupled with with CGIRB’s ISO 9001:2008 certification, AAHRPP accreditation, and existing corporate partnerships, will expand on CGIRB’s commitment to protect the rights and welfare of human subjects by providing innovative service offerings and quality review.
“We are pleased to provide this new offering to our clients who have requested additional service extending into Canada. It supports our dedication to superior quality and innovation,” said Bruce Tomason, CEO of CGIRB. “IRB Services is a highly regarded independent institutional review board with deep and insightful understanding of the Canadian research regulatory and ethical landscape nationally and in every province of the country. This alliance will further enhance our shared mission of human subject protection.”
Regulatory Compliance With eCOAs
April 26th 2024In the fourth and final part of this video interview with ACT editor Andy Studna, Melissa Mooney, director, eCOA sales engineering, IQVIA discusses how the regulatory stance on electronic clinical outcome assessments has changed over the years and what it could look like in the future.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.
